<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PBIOLOGY-D-11-00416</article-id><article-id pub-id-type="doi">10.1371/journal.pbio.1001038</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Primer</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
        </subj-group>
        
      </article-categories><title-group><article-title>Ubiquitylation in ERAD: Reversing to Go Forward?</article-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Tsai</surname>
            <given-names>Yien Che</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Weissman</surname>
            <given-names>Allan M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
                <addr-line>Laboratory of Protein Dynamics and Signaling, National Cancer Institute,
                    Frederick, Maryland, United States of America</addr-line>
            </aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">tsaiyien@mail.nih.gov</email> (YCT); <email xlink:type="simple">amw@nih.gov
                        or weissmaa@mail.nih.gov</email> (AMW)</corresp>
        <fn>
          <p>Primers provide a concise introduction into an important aspect of biology
                        highlighted by a current <italic>PLoS Biology</italic> research article.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <month>3</month>
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>29</day>
        <month>3</month>
        <year>2011</year>
      </pub-date><volume>9</volume><issue>3</issue><elocation-id>e1001038</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><license><license-p>This is an open-access article distributed under the terms of the
                Creative Commons Public Domain declaration which stipulates that, once placed in the
                public domain, this work may be freely reproduced, distributed, transmitted,
                modified, built upon, or otherwise used by anyone for any lawful
                purpose.</license-p></license></permissions><related-article id="RA1" issue="3" page="e1000605" related-article-type="companion" vol="9" xlink:href="info:doi/10.1371/journal.pbio.1000605" xlink:title="Research Article" xlink:type="simple">
                <article-title>Enzymatic blockade of the ubiquitin-proteasome pathway</article-title>
            </related-article><funding-group><funding-statement>This work was supported by the intramural research program of the National
                    Institutes of Health, National Cancer Institute, Center for Cancer Research. The
                    funders had no role in study design, data collection and analysis, decision to
                    publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="5"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s2">
      <title>Summary</title>
      <p>Proteins are co-translationally inserted into the endoplasmic reticulum (ER) where
                they undergo maturation. Homeostasis in the ER requires a highly sensitive and
                selective means of quality control. This occurs through ER-associated degradation
                (ERAD). This complex ubiquitin-proteasome–mediated process involves ubiquitin
                conjugating enzymes (E2) and ubiquitin ligases (E3), lumenal and cytosolic
                chaperones, and other proteins, including the AAA ATPase p97 (VCP; Cdc48 in yeast).
                Probing of processes involving proteasomal degradation has generally depended on
                proteasome inhibitors or knockdown of specific E2s or E3s. In this issue of
                    <italic>PLoS Biology</italic>, Ernst et al. demonstrate the utility of
                expressing the catalytic domain of a viral deubiquitylating enzyme to probe the
                ubiquitin system. Convincing evidence is provided that deubiquitylation is integral
                to dislocation of ERAD substrates from the ER membrane. The implications of this
                work for understanding ERAD and the potential of expressing deubiquitylating enzyme
                domains for studying ubiquitin-mediated processes are discussed.</p>
    </sec>
    <sec id="s3">
      <title>The Endoplasmic Reticulum, Protein Synthesis, and Degradation</title>
      <p>The membranous network that constitutes the endoplasmic reticulum (ER) plays
                essential roles in all metabolically active eukaryotic cells. The ER is contiguous
                with the nuclear envelope, yet it extends throughout the cytoplasm contacting
                mitochondria and coming in close proximity to the plasma membrane. This organelle
                plays important roles in cell metabolism, regulation of apoptosis, signal
                integration via calcium signaling, and sensing of the cell's microenvironment.
                Importantly, the ER is the port of entry for the vast majority of newly synthesized
                proteins that traverse the interconnected secretory and endocytic pathways. Proteins
                that are not normally occupants of the ER are transported by vesicular trafficking
                to the Golgi network. From there, these proteins reach their ultimate destinations
                as resident proteins of the secretory or endocytic pathways or the plasma membrane;
                alternatively, they are secreted from the cell. Proteins that enter the ER and
                traverse these pathways can constitute up to a third of synthesized proteins. It is
                therefore essential that the functional status of the ER be continually
                monitored.</p>
      <p>In general, proteins are co-translationally inserted into the ER through a narrow
                aqueous channel known as the Sec61 translocon <xref ref-type="bibr" rid="pbio.1001038-Rapoport1">[1]</xref>. This is coupled to early
                steps in protein maturation that can include the addition of N-linked
                oligosaccharides, which undergo further modification in the Golgi network, and
                complex chaperone-mediated folding that is often integrally associated with the
                formation of highly specific disulfide bonds <xref ref-type="bibr" rid="pbio.1001038-Kostova1">[2]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Vembar1">[3]</xref>. In many cases, these newly
                synthesized proteins also begin the process of assembly into complexes that
                ultimately result in functional receptors or channels. This requires that components
                “find each other” in the ER and oligomerize in a highly specific and
                ordered manner through interactions involving domains in the lumen of the ER and the
                ER membrane as well as their cytoplasmic domains.</p>
      <p>The complexity of the processes involved in protein folding and assembly and the need
                to regulate levels of critical resident proteins of the ER, such as HMG CoA
                reductase, requires the ER to have efficient and regulated means to dispose of
                unwanted proteins. Thus, much effort was expended in the 1980s and early ′90s
                towards identifying a proteolytic system in the ER or another pre-Golgi compartment
                using models including the pre-Golgi degradation of unassembled components of the T
                cell antigen receptor (TCR) <xref ref-type="bibr" rid="pbio.1001038-Klausner1">[4]</xref>. Eventually it became apparent that degradation of these
                unassembled subunits as well as other proteins does not occur within the secretory
                pathway. Instead, ER proteins are targeted for export to the cytosol where they are
                degraded, much as their cytosolic counterparts, by the ubiquitin-proteasome system
                (UPS) <xref ref-type="bibr" rid="pbio.1001038-Ward1">[5]</xref>–<xref ref-type="bibr" rid="pbio.1001038-Yang1">[9]</xref>. This takes place through a coordinated process known as
                ER-associated degradation (ERAD) <xref ref-type="bibr" rid="pbio.1001038-Vembar1">[3]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Werner1">[10]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Tsai1">[11]</xref> (<italic>vide infra</italic>).</p>
    </sec>
    <sec id="s4">
      <title>ER Stress and the Unfolded Protein Response</title>
      <p>Imbalance between neo-synthesis, degradation, and transport through the secretory
                pathway results in “ER stress” that, if left uncompensated, threatens
                cell function and survival and is linked to numerous pathologies, including
                neurodegenerative diseases, cancer, and diabetes <xref ref-type="bibr" rid="pbio.1001038-Zhao1">[12]</xref>. In higher eukaryotes, the state
                of the ER is continually monitored by at least three ER transmembrane sensors that
                each initiate a set of distinct but intersecting signaling pathways oriented towards
                maintaining ER homeostasis. This graded response, which is dependent on the degree
                of ER stress, is collectively known as the unfolded protein response (UPR) <xref ref-type="bibr" rid="pbio.1001038-Ron1">[13]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Malhotra1">[14]</xref>. The UPR
                upregulates the expression of genes involved in protein folding, modification,
                transport, and degradation, as well as redox regulation. The UPR also results in an
                increase in expression of enzymes for lipid biosynthesis, so as to increase the
                surface area of the ER. At the same time, the UPR inhibits global protein
                translation and reduces protein translation at the ER to reduce the protein load of
                the ER <xref ref-type="bibr" rid="pbio.1001038-Hollien1">[15]</xref>. This
                integrated response allows cells to conserve resources and overcome ER stress. If
                the UPR fails to restore ER homeostasis, cell death pathways are activated. One
                important mechanism for alleviating ER stress is by increasing degradation from the
                ER through UPR-mediated upregulation of ERAD components. Conversely, loss of ERAD
                components sensitizes cells to ER stress–induced apoptosis. The quality
                control/ERAD system becomes even more important during cellular stress, when small
                changes in the cell's ability to cope with ER stress can tip the balance
                towards either death or survival and proliferation <xref ref-type="bibr" rid="pbio.1001038-Tsai1">[11]</xref>.</p>
    </sec>
    <sec id="s5">
      <title>Endoplasmic Reticulum–Associated Degradation</title>
      <p>We now understand that ERAD involves substrate ubiquitylation and proteasomal
                degradation, which are tightly coupled to substrate dislocation from the ER. The
                conjugation of proteins with ubiquitin is a highly regulated process with
                specificity conferred by over 500 different ubiquitin ligases (E3s) working together
                with ubiquitin conjugating enzymes (E2s). The specific consequence of ubiquitylation
                is largely dependent on the nature of the polyubiquitin chain formed on target
                proteins. Besides proteasomal degradation, modification of proteins with single
                ubiquitin or polyubiquitin chains, commonly linked through different lysines of
                ubiquitin, can have other proteasome-independent functions in DNA repair, NF-κB
                activation, endocytosis, and lysosomal targeting, as well as other processes <xref ref-type="bibr" rid="pbio.1001038-Adhikari1">[16]</xref>.
                Ubiquitylation is opposed by the action of ∼100 mammalian deubiquitylating
                enzymes (DUBs) <xref ref-type="bibr" rid="pbio.1001038-Nijman1">[17]</xref>. DUBs perform many functions, including the
                deubiquitylation of specific substrates and disassembly of specific ubiquitin
                linkages (<xref ref-type="fig" rid="pbio-1001038-g001">Figure 1</xref>).</p>
      <fig id="pbio-1001038-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pbio.1001038.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Roles of ubiquitylation in cellular regulation.</title>
          <p>Conjugation of ubiquitin onto protein substrates requires at least three
                        enzymes. One of two ubiquitin activating enzymes (E1) activates ubiquitin
                        through an ATP-dependent step, forming a thioester linkage between the
                        active site cysteine of E1 and the C-terminal carboxylate of ubiquitin. E1
                        then transfers the ubiquitin to the active site cysteine of one of
                        approximately 40 mammalian ubiquitin conjugating enzymes (E2). The ubiquitin
                        can be transferred to the active site of a HECT domain ubiquitin ligase
                        (E3), which binds the substrate and mediates the conjugation of ubiquitin.
                        RING finger and related E3s function as allosteric activators of E2,
                        promoting the transfer of ubiquitin directly from the E2 to the substrate.
                        The combination of E2/E3 determines the length and type of polyubiquitin
                        chains assembled on the substrate, which can lead to diverse cellular
                        effects, some of which are noted. Ubiquitylation is best characterized as
                        modifying primary amines (lysines and the N-termini of proteins) <xref ref-type="bibr" rid="pbio.1001038-Ciechanover1">[44]</xref>.
                        More recently, there has been evidence that other nucleophillic amino acids
                        including serine, threonine, and cysteine can also be modified with
                        polyubiquitin chains <xref ref-type="bibr" rid="pbio.1001038-Wang1">[45]</xref>–<xref ref-type="bibr" rid="pbio.1001038-Ishikura1">[48]</xref>. DUBs perform a
                        number of cellular roles, including removing ubiquitin from specific
                        substrates. There are at least five classes of DUBs, and many DUBs show
                        strong preferences for specific polyubiquitin chain linkages.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001038.g001" xlink:type="simple"/>
      </fig>
      <p>The ERAD ubiquitylation machinery in both yeast and mammals consists primarily of
                ER-resident transmembrane E3s and their cognate E2s. In several cases, particularly
                in mammals, multiple E3s are implicated in the degradation of a specific substrate.
                DUBs can counteract the activity of ubiquitin ligases towards specific ERAD
                substrates <xref ref-type="bibr" rid="pbio.1001038-Zhong1">[18]</xref>,
                although the roles of DUBs in ERAD have not been extensively explored.</p>
      <p>Intense interest has been focused on identification of the protein conducting
                channel(s) through which misfolded proteins can be exported from the ER to the
                cytosol—a process variously referred to as “retrotranslocation” or
                “dislocation.” Early studies suggested that Sec61, the import channel
                for proteins into the ER, might also be the retrotranslocon through which this
                dislocation is effected <xref ref-type="bibr" rid="pbio.1001038-Wiertz1">[8]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Plemper1">[19]</xref>–<xref ref-type="bibr" rid="pbio.1001038-Scott1">[21]</xref>. Another such candidate is Derlin-1, a polytopic protein
                implicated in the targeting of several substrates for degradation <xref ref-type="bibr" rid="pbio.1001038-Lilley1">[22]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Ye1">[23]</xref>. In addition,
                polytopic ER-resident ubiquitin ligases such as Hrd1 have been suggested to form
                part of this channel <xref ref-type="bibr" rid="pbio.1001038-Carvalho1">[24]</xref>. As Sec61 imports nascent polypeptides into the ER in an
                unfolded state, a reasonable assumption is that protein unfolding is likely required
                for retrotranslocation. However, it is not evident that this is uniformly the case
                    <xref ref-type="bibr" rid="pbio.1001038-Fiebiger1">[25]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Tirosh1">[26]</xref>.</p>
      <p>For transmembrane proteins with cytosolic domains, the topological conundrum of being
                ubiquitylated and degraded from the ER is easily conceptualized. Exposed domains of
                substrates serve as targets for the ubiquitylation machinery associated with
                retrotranslocons (<xref ref-type="fig" rid="pbio-1001038-g002">Figure 2</xref>).
                Ubiquitylated species are “ratcheted” out of the ER in an ATP-driven
                process provided by complexes of the hexameric AAA-ATPase p97 (Cdc48 in yeast) and
                associated ubiquitin-binding proteins <xref ref-type="bibr" rid="pbio.1001038-Lilley2">[27]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Ye2">[28]</xref>; these complexes are also
                implicated as intermediates in the proteasomal targeting of non-ER proteins <xref ref-type="bibr" rid="pbio.1001038-Richly1">[29]</xref>. At least in
                yeast, there is evidence that other ubiquitin-binding “shuttle proteins”
                play a role in delivering dislocated substrates from p97 complexes to proteasomes
                    <xref ref-type="bibr" rid="pbio.1001038-Medicherla1">[30]</xref>. For
                those proteins that reside in the lumen of the ER, the means by which they are
                retrotranslocated is conceptually more difficult to envision. However, we now
                understand that lumenal chaperones can associate with at least one of the
                transmembrane ubiquitin ligase complexes and deliver proteins to sites of
                ubiquitylation <xref ref-type="bibr" rid="pbio.1001038-Christianson1">[31]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Clerc1">[32]</xref>.</p>
      <fig id="pbio-1001038-g002" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pbio.1001038.g002</object-id>
        <label>Figure 2</label>
        <caption>
          <title>Models for ERAD.</title>
          <p>(a–c) Classical view of ERAD. (a) ERAD substrate (black) is recognized
                        by ER chaperones and partially translocated through a protein conducting
                        channel complex/retrotranslocon (brown). The substrate is conjugated with
                        chains of ubiquitin by an ER-resident ubiquitin ligase (E3) and its cognate
                        ubiquitin conjugating enzyme (E2) on the cytosolic face of the ER membrane.
                        (b) The p97 complex, comprising a hexamer of the AAA ATPase p97 and
                        accessory proteins such as Ufd1 and Npl4 (not depicted), associates with the
                        retrotranslocation complex, recognizes the polyubiquitin chain and extracts
                        the ubiquitylated substrate to the cytosol. (c) Polyubiquitin chains target
                        the dislocated substrate to the 26S proteasome (magenta) for degradation, in
                        some cases assisted by shuttle proteins (pink) that bind both to ubiquitin
                        chains and the proteasome. (d–f) Model based on results in Ernst et
                        al. <xref ref-type="bibr" rid="pbio.1001038-Ernst1">[33]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Ernst2">[36]</xref>. The exact mechanism by which the p97 complex
                        extracts the substrate is not well understood. These new findings suggest
                        that (d) the p97 complex recognizes polyubiquitin chains on the substrate as
                        it moves through the protein-conducting channel. (e) DUBs associated with
                        the p97 complex (purple) or potentially free in the cytosol (green) trim off
                        the polyubiquitin chain on the substrate, allowing it to be threaded into
                        the narrow channel of the p97 complex. (f) The dislocated substrate is
                        ubiquitylated a second time by either ER-resident or cytosolic E3s for
                        targeting to the proteasome (depicted in [c]).</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001038.g002" xlink:type="simple"/>
      </fig>
    </sec>
    <sec id="s6">
      <title>Deubiquitylation as an Integral Step in ERAD</title>
      <p>A recent study by Ernst and colleagues has provided a new and interesting twist to
                ERAD <xref ref-type="bibr" rid="pbio.1001038-Ernst1">[33]</xref>. The p97
                complex has been found to be associated with several deubiquitylating enzymes,
                including YOD1 and USP13 <xref ref-type="bibr" rid="pbio.1001038-Sowa1">[34]</xref>. YOD1 interacts with p97 via its UBX domain. Transfection
                of a catalytically inactive form of YOD1 blocks dislocation of model ERAD substrates
                    <xref ref-type="bibr" rid="pbio.1001038-Ernst1">[33]</xref>. This
                result suggests that deubiquitylation is required for protein dislocation from the
                ER (<xref ref-type="fig" rid="pbio-1001038-g002">Figure 2</xref>). This is a finding
                that at first seems counterintuitive, given the wealth of evidence suggesting a role
                for ubiquitylation in this process. One possibility is that, analogous to threading
                of the substrate into the narrow channel of the proteasome, protein dislocation
                might require trimming off the polyubiquitin chain to allow the substrate to enter
                the central channel of the p97 complex during retrotranslocation. While highly
                provocative, these results involve overexpression of a “dominant
                negative” form of YOD1. This overexpression could potentially interfere with
                the binding to p97 of other important UBX domain-containing components of the ERAD
                machinery <xref ref-type="bibr" rid="pbio.1001038-Schuberth1">[35]</xref>.
                Thus, the possibility that the results obtained were an indirect effect of
                disrupting other p97 interactions could not be discounted.</p>
      <p>Until now, with few exceptions, probing of the UPS in general and ERAD in particular
                has relied on either manipulation of substrate-specific enzymes of the ubiquitin
                system or use of proteasome inhibitors. In the current issue, Ernst and colleagues
                    <xref ref-type="bibr" rid="pbio.1001038-Ernst2">[36]</xref> unveil a
                new tool for inhibiting protein degradation—the catalytic domain of a DUB
                encoded by the Epstein-Barr virus (EBV). The authors show that the isolated EBV DUB
                domain inhibits degradation of proteasome substrates, likely due to preemptive
                removal of ubiquitin from the substrates. Interestingly, cells tolerate expression
                of the EBV DUB better than proteasome inhibitors. They then employ this tool to
                follow up on the aforementioned study on the role of DUB activity in protein
                dislocation.</p>
      <p>By fusing the catalytic domain of EBV DUB with a UBX domain, Ernst et al. target the
                EBV DUB domain to p97-containing complexes. Expression of this UBX-EBV DUB also
                results in accumulation of ERAD substrates. For two model substrates, a mutant
                ribophorin RI<sub>332</sub> and TCRα, accumulation of deglycosylated
                intermediates suggest that these proteins are largely dislocated, since N-glycanase,
                which is responsible for removing N-linked oligosaccharides from proteins, is
                confined to the cytosol. Subcellular fractionation and microscopy confirm that the
                substrates are dislocated but remain loosely associated with the ER membrane. The
                authors then take advantage of this p97-targeted DUB to further probe the role of
                ubiquitylation during ERAD. Strikingly, expression of UBX-EBV DUB restores protein
                dislocation in the presence of catalytically inactive YOD1. The dislocated
                substrates accumulate in the cytosol as deglycosylated and deubiquitylated
                intermediates. These results reinforce the idea that deubiquitylation is necessary
                for substrate dislocation. However, as the EBV DUB overcomes the inhibitory effect
                of inactive YOD1 even when not targeted to p97 via a UBX domain, it leaves
                unanswered whether, for endogenous DUBs, p97 association is truly required for their
                recruitment to the ER and function in ERAD. It also remains to be formally
                established whether the critical targets for this deubiquitylation step are the ERAD
                substrates, although this is certainly the most likely scenario. Such a model would
                then require at least two rounds of ubiquitylation to occur during ERAD. The first
                round is essential for p97 recognition and dislocation. The second round, following
                substrate deubiquitylation, is essential for proteasomal targeting of the now
                dislocated protein.</p>
    </sec>
    <sec id="s7">
      <title>Cytosolic Chaperones in ERAD</title>
      <p>As proteins dislocated from the ER may be partially unfolded, an important question
                is how they are maintained in a soluble form in the cytosol. Previous studies have
                shown that cytosolic chaperones are involved in the degradation of certain ERAD
                substrates <xref ref-type="bibr" rid="pbio.1001038-Huyer1">[37]</xref>–<xref ref-type="bibr" rid="pbio.1001038-Park1">[40]</xref>. Employing chemical inhibitors or mutants of the
                dislocation machineries, Ernst et al. utilized mass spectrometry to identify
                proteins interacting with a model ERAD substrate, RI<sub>332</sub>, when protein
                dislocation is disrupted at different stages. This approach should in principle
                allow for a systematic and unbiased discovery of factors involved in the various
                stages of ERAD. For example, expression of UBX-EBV DUB or treatment with proteasome
                inhibitors arrests some percentage of the substrate at a step after dislocation.
                Under these conditions, RI<sub>332</sub> associates with cytosolic chaperones,
                supporting the idea that a cytosolic chaperone network buffers the dislocated
                substrate and allows their subsequent degradation by the proteasome. The role of
                these cytosolic chaperones in ERAD awaits further studies.</p>
    </sec>
    <sec id="s8">
      <title>Future Directions</title>
      <p>These recent findings raise new questions regarding ERAD and illustrate the utility
                of DUBs in studying the UPS. If substrate deubiquitylation is required for
                retro-translocation, an important question now becomes what components of UPS
                participate in the subsequent proteasomal-targeting step of dislocated substrates.
                As dislocated substrates stay loosely associated with the ER membrane, it would be
                interesting to determine whether this second round of ubiquitylation is carried out
                by the same ERAD ubiquitin ligases that initiate dislocation, or whether cytosolic
                ubiquitin ligases now assume control. If cytosolic ubiquitin ligases are involved,
                are they specialized for dislocated substrates or do they overlap with those
                implicated in cytosolic quality control? In this regard, it is of note that
                HSP70-associated E3s including Parkin and CHIP have been implicated in the
                degradation of some ERAD substrates <xref ref-type="bibr" rid="pbio.1001038-Imai1">[41]</xref>,<xref ref-type="bibr" rid="pbio.1001038-Younger1">[42]</xref>.</p>
      <p>A major point accentuated by the current findings of Ernst et al. <xref ref-type="bibr" rid="pbio.1001038-Ernst2">[36]</xref> is that DUB
                catalytic domains can be used to inhibit and probe the ubiquitin conjugating system
                in ways that might not be achieved by proteasome inhibitors. While the use of such
                domains can provide important new insights, interpretation of results obtained using
                these tools have important caveats. These include the fact that, aside from
                subcellular localization, outcome of expressing a DUB domain will likely be highly
                dependent on its relative in vivo specificity for different ubiquitin linkages. The
                specificity of DUBs for different polyubiquitin chain linkages varies considerably.
                Therefore, results obtained with expression of particular DUBs will need to be
                interpreted in this context.</p>
      <p>Another attractive means of utilizing DUB catalytic domains is to covalently fuse
                them with proteins that have restricted subcellular localization to probe specific
                functions of ubiquitylation in the cell. An isolated DUB catalytic domain can also
                be fused to the target protein to inhibit ubiquitylation of the fusion protein. This
                strategy has recently allowed the dissection of the role of ubiquitylation in
                endosomal targeting in yeast <xref ref-type="bibr" rid="pbio.1001038-Stringer1">[43]</xref>. This approach, as well as variations on the one employed
                in this issue, opens up exciting new possibilities for probing the function of
                ubiquitylation in cellular regulation.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pbio.1001038-Rapoport1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Rapoport</surname><given-names>T. A</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>Protein translocation across the eukaryotic endoplasmic reticulum
                        and bacterial plasma membranes.</article-title>
                    <source>Nature</source>
                    <volume>450</volume>
                    <fpage>663</fpage>
                    <lpage>669</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Kostova1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Kostova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>D. H</given-names></name></person-group>
                    <year>2003</year>
                    <article-title>For whom the bell tolls: protein quality control of the
                        endoplasmic reticulum and the ubiquitin-proteasome
                        connection.</article-title>
                    <source>Embo J</source>
                    <volume>22</volume>
                    <fpage>2309</fpage>
                    <lpage>2317</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Vembar1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Vembar</surname><given-names>S. S</given-names></name><name name-style="western"><surname>Brodsky</surname><given-names>J. L</given-names></name></person-group>
                    <year>2008</year>
                    <article-title>One step at a time: endoplasmic reticulum-associated
                        degradation.</article-title>
                    <source>Nat Rev Mol Cell Biol</source>
                    <volume>9</volume>
                    <fpage>944</fpage>
                    <lpage>957</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Klausner1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Klausner</surname><given-names>R. D</given-names></name><name name-style="western"><surname>Sitia</surname><given-names>R</given-names></name></person-group>
                    <year>1990</year>
                    <article-title>Protein degradation in the endoplasmic reticulum.</article-title>
                    <source>Cell</source>
                    <volume>62</volume>
                    <fpage>611</fpage>
                    <lpage>614</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ward1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ward</surname><given-names>C. L</given-names></name><name name-style="western"><surname>Omura</surname><given-names>S</given-names></name><name name-style="western"><surname>Kopito</surname><given-names>R. R</given-names></name></person-group>
                    <year>1995</year>
                    <article-title>Degradation of CFTR by the ubiquitin-proteasome
                        pathway.</article-title>
                    <source>Cell</source>
                    <volume>83</volume>
                    <fpage>121</fpage>
                    <lpage>127</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Jensen1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>T. J</given-names></name><name name-style="western"><surname>Loo</surname><given-names>M. A</given-names></name><name name-style="western"><surname>Pind</surname><given-names>S</given-names></name><name name-style="western"><surname>Williams</surname><given-names>D. B</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>A. L</given-names></name><etal/></person-group>
                    <year>1995</year>
                    <article-title>Multiple proteolytic systems, including the proteasome,
                        contribute to CFTR processing.</article-title>
                    <source>Cell</source>
                    <volume>83</volume>
                    <fpage>129</fpage>
                    <lpage>135</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Hiller1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hiller</surname><given-names>M. M</given-names></name><name name-style="western"><surname>Finger</surname><given-names>A</given-names></name><name name-style="western"><surname>Schweiger</surname><given-names>M</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>D. H</given-names></name></person-group>
                    <year>1996</year>
                    <article-title>ER degradation of a misfolded luminal protein by the cytosolic
                        ubiquitin-proteasome pathway.</article-title>
                    <source>Science</source>
                    <volume>273</volume>
                    <fpage>1725</fpage>
                    <lpage>1728</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Wiertz1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Wiertz</surname><given-names>E. J</given-names></name><name name-style="western"><surname>Tortorella</surname><given-names>D</given-names></name><name name-style="western"><surname>Bogyo</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Mothes</surname><given-names>W</given-names></name><etal/></person-group>
                    <year>1996</year>
                    <article-title>Sec61-mediated transfer of a membrane protein from the
                        endoplasmic reticulum to the proteasome for destruction.</article-title>
                    <source>Nature</source>
                    <volume>384</volume>
                    <fpage>432</fpage>
                    <lpage>438</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Yang1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Omura</surname><given-names>S</given-names></name><name name-style="western"><surname>Bonifacino</surname><given-names>J. S</given-names></name><name name-style="western"><surname>Weissman</surname><given-names>A. M</given-names></name></person-group>
                    <year>1998</year>
                    <article-title>Novel aspects of degradation of T cell receptor subunits from the
                        endoplasmic reticulum (ER) in T cells: importance of oligosaccharide
                        processing, ubiquitination, and proteasome-dependent removal from ER
                        membranes.</article-title>
                    <source>J Exp Med</source>
                    <volume>187</volume>
                    <fpage>835</fpage>
                    <lpage>846</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Werner1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Werner</surname><given-names>E. D</given-names></name><name name-style="western"><surname>Brodsky</surname><given-names>J. L</given-names></name><name name-style="western"><surname>McCracken</surname><given-names>A. A</given-names></name></person-group>
                    <year>1996</year>
                    <article-title>Proteasome-dependent endoplasmic reticulum-associated protein
                        degradation: an unconventional route to a familiar fate.</article-title>
                    <source>Proc Natl Acad Sci U S A</source>
                    <volume>93</volume>
                    <fpage>13797</fpage>
                    <lpage>13801</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Tsai1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>Y. C</given-names></name><name name-style="western"><surname>Weissman</surname><given-names>A. M</given-names></name></person-group>
                    <year>2010</year>
                    <article-title>The Unfolded Protein Response, Degradation from the Endoplasmic
                        Reticulum, and Cancer.</article-title>
                    <source>Genes &amp; Cancer</source>
                    <volume>1</volume>
                    <fpage>764</fpage>
                    <lpage>778</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Zhao1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>S. L</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Endoplasmic reticulum stress in health and
                        disease.</article-title>
                    <source>Curr Opin Cell Biol</source>
                    <volume>18</volume>
                    <fpage>444</fpage>
                    <lpage>452</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ron1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ron</surname><given-names>D</given-names></name><name name-style="western"><surname>Walter</surname><given-names>P</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>Signal integration in the endoplasmic reticulum unfolded protein
                        response.</article-title>
                    <source>Nat Rev Mol Cell Biol</source>
                    <volume>8</volume>
                    <fpage>519</fpage>
                    <lpage>529</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Malhotra1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Malhotra</surname><given-names>J. D</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>R. J</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>The endoplasmic reticulum and the unfolded protein
                        response.</article-title>
                    <source>Semin Cell Dev Biol</source>
                    <volume>18</volume>
                    <fpage>716</fpage>
                    <lpage>731</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Hollien1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hollien</surname><given-names>J</given-names></name><name name-style="western"><surname>Weissman</surname><given-names>J. S</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Decay of endoplasmic reticulum-localized mRNAs during the
                        unfolded protein response.</article-title>
                    <source>Science</source>
                    <volume>313</volume>
                    <fpage>104</fpage>
                    <lpage>107</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Adhikari1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Adhikari</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z. J</given-names></name></person-group>
                    <year>2009</year>
                    <article-title>Diversity of polyubiquitin chains.</article-title>
                    <source>Dev Cell</source>
                    <volume>16</volume>
                    <fpage>485</fpage>
                    <lpage>486</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Nijman1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Nijman</surname><given-names>S. M</given-names></name><name name-style="western"><surname>Luna-Vargas</surname><given-names>M. P</given-names></name><name name-style="western"><surname>Velds</surname><given-names>A</given-names></name><name name-style="western"><surname>Brummelkamp</surname><given-names>T. R</given-names></name><name name-style="western"><surname>Dirac</surname><given-names>A. M</given-names></name><etal/></person-group>
                    <year>2005</year>
                    <article-title>A genomic and functional inventory of deubiquitinating
                        enzymes.</article-title>
                    <source>Cell</source>
                    <volume>123</volume>
                    <fpage>773</fpage>
                    <lpage>786</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Zhong1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>X</given-names></name><name name-style="western"><surname>Pittman</surname><given-names>R. N</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD
                        substrates.</article-title>
                    <source>Hum Mol Genet</source>
                    <volume>15</volume>
                    <fpage>2409</fpage>
                    <lpage>2420</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Plemper1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Plemper</surname><given-names>R. K</given-names></name><name name-style="western"><surname>Bohmler</surname><given-names>S</given-names></name><name name-style="western"><surname>Bordallo</surname><given-names>J</given-names></name><name name-style="western"><surname>Sommer</surname><given-names>T</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>D. H</given-names></name></person-group>
                    <year>1997</year>
                    <article-title>Mutant analysis links the translocon and BiP to retrograde
                        protein transport for ER degradation.</article-title>
                    <source>Nature</source>
                    <volume>388</volume>
                    <fpage>891</fpage>
                    <lpage>895</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Pilon1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Pilon</surname><given-names>M</given-names></name><name name-style="western"><surname>Schekman</surname><given-names>R</given-names></name><name name-style="western"><surname>Romisch</surname><given-names>K</given-names></name></person-group>
                    <year>1997</year>
                    <article-title>Sec61p mediates export of a misfolded secretory protein from the
                        endoplasmic reticulum to the cytosol for degradation.</article-title>
                    <source>Embo J</source>
                    <volume>16</volume>
                    <fpage>4540</fpage>
                    <lpage>4548</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Scott1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>D. C</given-names></name><name name-style="western"><surname>Schekman</surname><given-names>R</given-names></name></person-group>
                    <year>2008</year>
                    <article-title>Role of Sec61p in the ER-associated degradation of short-lived
                        transmembrane proteins.</article-title>
                    <source>J Cell Biol</source>
                    <volume>181</volume>
                    <fpage>1095</fpage>
                    <lpage>1105</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Lilley1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Lilley</surname><given-names>B. N</given-names></name><name name-style="western"><surname>Ploegh</surname><given-names>H. L</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>A membrane protein required for dislocation of misfolded proteins
                        from the ER.</article-title>
                    <source>Nature</source>
                    <volume>429</volume>
                    <fpage>834</fpage>
                    <lpage>840</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ye1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yun</surname><given-names>C</given-names></name><name name-style="western"><surname>Ron</surname><given-names>D</given-names></name><name name-style="western"><surname>Rapoport</surname><given-names>T. A</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>A membrane protein complex mediates retro-translocation from the
                        ER lumen into the cytosol.</article-title>
                    <source>Nature</source>
                    <volume>429</volume>
                    <fpage>841</fpage>
                    <lpage>847</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Carvalho1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Carvalho</surname><given-names>P</given-names></name><name name-style="western"><surname>Stanley</surname><given-names>A. M</given-names></name><name name-style="western"><surname>Rapoport</surname><given-names>T. A</given-names></name></person-group>
                    <article-title>Retrotranslocation of a misfolded luminal ER protein by the
                        ubiquitin-ligase Hrd1p.</article-title>
                    <source>Cell</source>
                    <volume>143</volume>
                    <fpage>579</fpage>
                    <lpage>591</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Fiebiger1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Fiebiger</surname><given-names>E</given-names></name><name name-style="western"><surname>Story</surname><given-names>C</given-names></name><name name-style="western"><surname>Ploegh</surname><given-names>H. L</given-names></name><name name-style="western"><surname>Tortorella</surname><given-names>D</given-names></name></person-group>
                    <year>2002</year>
                    <article-title>Visualization of the ER-to-cytosol dislocation reaction of a type
                        I membrane protein.</article-title>
                    <source>Embo J</source>
                    <volume>21</volume>
                    <fpage>1041</fpage>
                    <lpage>1053</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Tirosh1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Tirosh</surname><given-names>B</given-names></name><name name-style="western"><surname>Furman</surname><given-names>M. H</given-names></name><name name-style="western"><surname>Tortorella</surname><given-names>D</given-names></name><name name-style="western"><surname>Ploegh</surname><given-names>H. L</given-names></name></person-group>
                    <year>2003</year>
                    <article-title>Protein unfolding is not a prerequisite for endoplasmic
                        reticulum-to-cytosol dislocation.</article-title>
                    <source>J Biol Chem</source>
                    <volume>278</volume>
                    <fpage>6664</fpage>
                    <lpage>6672</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Lilley2">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Lilley</surname><given-names>B. N</given-names></name><name name-style="western"><surname>Ploegh</surname><given-names>H. L</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>Multiprotein complexes that link dislocation, ubiquitination, and
                        extraction of misfolded proteins from the endoplasmic reticulum
                        membrane.</article-title>
                    <source>Proc Natl Acad Sci U S A</source>
                    <volume>102</volume>
                    <fpage>14296</fpage>
                    <lpage>14301</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ye2">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kikkert</surname><given-names>M</given-names></name><name name-style="western"><surname>van Voorden</surname><given-names>S</given-names></name><name name-style="western"><surname>Wiertz</surname><given-names>E</given-names></name><etal/></person-group>
                    <year>2005</year>
                    <article-title>Recruitment of the p97 ATPase and ubiquitin ligases to the site
                        of retrotranslocation at the endoplasmic reticulum membrane.</article-title>
                    <source>Proc Natl Acad Sci U S A</source>
                    <volume>102</volume>
                    <fpage>14132</fpage>
                    <lpage>14138</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Richly1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Richly</surname><given-names>H</given-names></name><name name-style="western"><surname>Rape</surname><given-names>M</given-names></name><name name-style="western"><surname>Braun</surname><given-names>S</given-names></name><name name-style="western"><surname>Rumpf</surname><given-names>S</given-names></name><name name-style="western"><surname>Hoege</surname><given-names>C</given-names></name><etal/></person-group>
                    <year>2005</year>
                    <article-title>A series of ubiquitin binding factors connects CDC48/p97 to
                        substrate multiubiquitylation and proteasomal targeting.</article-title>
                    <source>Cell</source>
                    <volume>120</volume>
                    <fpage>73</fpage>
                    <lpage>84</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Medicherla1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Medicherla</surname><given-names>B</given-names></name><name name-style="western"><surname>Kostova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>A</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>D. H</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>A genomic screen identifies Dsk2p and Rad23p as essential
                        components of ER-associated degradation.</article-title>
                    <source>EMBO Rep</source>
                    <volume>5</volume>
                    <fpage>692</fpage>
                    <lpage>697</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Christianson1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Christianson</surname><given-names>J. C</given-names></name><name name-style="western"><surname>Shaler</surname><given-names>T. A</given-names></name><name name-style="western"><surname>Tyler</surname><given-names>R. E</given-names></name><name name-style="western"><surname>Kopito</surname><given-names>R. R</given-names></name></person-group>
                    <year>2008</year>
                    <article-title>OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the
                        Hrd1-SEL1L ubiquitin ligase complex for ERAD.</article-title>
                    <source>Nat Cell Biol</source>
                    <volume>10</volume>
                    <fpage>272</fpage>
                    <lpage>282</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Clerc1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Clerc</surname><given-names>S</given-names></name><name name-style="western"><surname>Hirsch</surname><given-names>C</given-names></name><name name-style="western"><surname>Oggier</surname><given-names>D. M</given-names></name><name name-style="western"><surname>Deprez</surname><given-names>P</given-names></name><name name-style="western"><surname>Jakob</surname><given-names>C</given-names></name><etal/></person-group>
                    <year>2009</year>
                    <article-title>Htm1 protein generates the N-glycan signal for glycoprotein
                        degradation in the endoplasmic reticulum.</article-title>
                    <source>J Cell Biol</source>
                    <volume>184</volume>
                    <fpage>159</fpage>
                    <lpage>172</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ernst1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ernst</surname><given-names>R</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>B</given-names></name><name name-style="western"><surname>Ploegh</surname><given-names>H. L</given-names></name><name name-style="western"><surname>Schlieker</surname><given-names>C</given-names></name></person-group>
                    <year>2009</year>
                    <article-title>The otubain YOD1 is a deubiquitinating enzyme that associates
                        with p97 to facilitate protein dislocation from the ER.</article-title>
                    <source>Mol Cell</source>
                    <volume>36</volume>
                    <fpage>28</fpage>
                    <lpage>38</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Sowa1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Sowa</surname><given-names>M. E</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>E. J</given-names></name><name name-style="western"><surname>Gygi</surname><given-names>S. P</given-names></name><name name-style="western"><surname>Harper</surname><given-names>J. W</given-names></name></person-group>
                    <year>2009</year>
                    <article-title>Defining the human deubiquitinating enzyme interaction
                        landscape.</article-title>
                    <source>Cell</source>
                    <volume>138</volume>
                    <fpage>389</fpage>
                    <lpage>403</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Schuberth1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Schuberth</surname><given-names>C</given-names></name><name name-style="western"><surname>Buchberger</surname><given-names>A</given-names></name></person-group>
                    <year>2008</year>
                    <article-title>UBX domain proteins: major regulators of the AAA ATPase
                        Cdc48/p97.</article-title>
                    <source>Cell Mol Life Sci</source>
                    <volume>65</volume>
                    <fpage>2360</fpage>
                    <lpage>2371</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ernst2">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ernst</surname><given-names>R</given-names></name><name name-style="western"><surname>Claessen</surname><given-names>J. H. L</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>B</given-names></name><name name-style="western"><surname>Sanyal</surname><given-names>S</given-names></name><name name-style="western"><surname>Spooner</surname><given-names>E</given-names></name><etal/></person-group>
                    <year>2011</year>
                    <article-title>Enzymatic blockade of the ubiquitin-proteasome
                        pathway.</article-title>
                    <source>PLoS Biol</source>
                    <volume>9</volume>
                    <fpage>e1000605</fpage>
                    <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.1000605" xlink:type="simple">10.1371/journal.pbio.1000605</ext-link></comment>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Huyer1">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Huyer</surname><given-names>G</given-names></name><name name-style="western"><surname>Piluek</surname><given-names>W. F</given-names></name><name name-style="western"><surname>Fansler</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kreft</surname><given-names>S. G</given-names></name><name name-style="western"><surname>Hochstrasser</surname><given-names>M</given-names></name><etal/></person-group>
                    <year>2004</year>
                    <article-title>Distinct machinery is required in Saccharomyces cerevisiae for
                        the endoplasmic reticulum-associated degradation of a multispanning membrane
                        protein and a soluble luminal protein.</article-title>
                    <source>J Biol Chem</source>
                    <volume>279</volume>
                    <fpage>38369</fpage>
                    <lpage>38378</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Nishikawa1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Nishikawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Brodsky</surname><given-names>J. L</given-names></name><name name-style="western"><surname>Nakatsukasa</surname><given-names>K</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>Roles of molecular chaperones in endoplasmic reticulum (ER)
                        quality control and ER-associated degradation (ERAD).</article-title>
                    <source>J Biochem</source>
                    <volume>137</volume>
                    <fpage>551</fpage>
                    <lpage>555</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Hrizo1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hrizo</surname><given-names>S. L</given-names></name><name name-style="western"><surname>Gusarova</surname><given-names>V</given-names></name><name name-style="western"><surname>Habiel</surname><given-names>D. M</given-names></name><name name-style="western"><surname>Goeckeler</surname><given-names>J. L</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>E. A</given-names></name><etal/></person-group>
                    <year>2007</year>
                    <article-title>The Hsp110 molecular chaperone stabilizes apolipoprotein B from
                        endoplasmic reticulum-associated degradation (ERAD).</article-title>
                    <source>J Biol Chem</source>
                    <volume>282</volume>
                    <fpage>32665</fpage>
                    <lpage>32675</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Park1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S. H</given-names></name><name name-style="western"><surname>Bolender</surname><given-names>N</given-names></name><name name-style="western"><surname>Eisele</surname><given-names>F</given-names></name><name name-style="western"><surname>Kostova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>J</given-names></name><etal/></person-group>
                    <year>2007</year>
                    <article-title>The cytoplasmic Hsp70 chaperone machinery subjects misfolded and
                        endoplasmic reticulum import-incompetent proteins to degradation via the
                        ubiquitin-proteasome system.</article-title>
                    <source>Mol Biol Cell</source>
                    <volume>18</volume>
                    <fpage>153</fpage>
                    <lpage>165</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Imai1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Imai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Soda</surname><given-names>M</given-names></name><name name-style="western"><surname>Hatakeyama</surname><given-names>S</given-names></name><name name-style="western"><surname>Akagi</surname><given-names>T</given-names></name><name name-style="western"><surname>Hashikawa</surname><given-names>T</given-names></name><etal/></person-group>
                    <year>2002</year>
                    <article-title>CHIP is associated with Parkin, a gene responsible for familial
                        Parkinson's disease, and enhances its ubiquitin ligase
                        activity.</article-title>
                    <source>Mol Cell</source>
                    <volume>10</volume>
                    <fpage>55</fpage>
                    <lpage>67</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Younger1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Younger</surname><given-names>J. M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Ren</surname><given-names>H. Y</given-names></name><name name-style="western"><surname>Rosser</surname><given-names>M. F</given-names></name><name name-style="western"><surname>Turnbull</surname><given-names>E. L</given-names></name><etal/></person-group>
                    <year>2006</year>
                    <article-title>Sequential quality-control checkpoints triage misfolded cystic
                        fibrosis transmembrane conductance regulator.</article-title>
                    <source>Cell</source>
                    <volume>126</volume>
                    <fpage>571</fpage>
                    <lpage>582</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Stringer1">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Stringer</surname><given-names>D. K</given-names></name><name name-style="western"><surname>Piper</surname><given-names>R. C</given-names></name></person-group>
                    <year>2011</year>
                    <article-title>A single ubiquitin is sufficient for cargo protein entry into
                        MVBs in the absence of ESCRT ubiquitination.</article-title>
                    <source>J Cell Biol</source>
                    <volume>192</volume>
                    <fpage>229</fpage>
                    <lpage>242</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ciechanover1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ciechanover</surname><given-names>A</given-names></name><name name-style="western"><surname>Ben-Saadon</surname><given-names>R</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>N-terminal ubiquitination: more protein substrates join
                        in.</article-title>
                    <source>Trends Cell Biol</source>
                    <volume>14</volume>
                    <fpage>103</fpage>
                    <lpage>106</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Wang1">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Herr</surname><given-names>R. A</given-names></name><name name-style="western"><surname>Chua</surname><given-names>W. J</given-names></name><name name-style="western"><surname>Lybarger</surname><given-names>L</given-names></name><name name-style="western"><surname>Wiertz</surname><given-names>E. J</given-names></name><etal/></person-group>
                    <year>2007</year>
                    <article-title>Ubiquitination of serine, threonine, or lysine residues on the
                        cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase
                        mK3.</article-title>
                    <source>J Cell Biol</source>
                    <volume>177</volume>
                    <fpage>613</fpage>
                    <lpage>624</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ravid1">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ravid</surname><given-names>T</given-names></name><name name-style="western"><surname>Hochstrasser</surname><given-names>M</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its
                        catalytic residue.</article-title>
                    <source>Nat Cell Biol</source>
                    <volume>9</volume>
                    <fpage>422</fpage>
                    <lpage>427</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Shimizu1">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Okuda-Shimizu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hendershot</surname><given-names>L. M</given-names></name></person-group>
                    <year>2010</year>
                    <article-title>Ubiquitylation of an ERAD substrate occurs on multiple types of
                        amino acids.</article-title>
                    <source>Mol Cell</source>
                    <volume>40</volume>
                    <fpage>917</fpage>
                    <lpage>926</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001038-Ishikura1">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ishikura</surname><given-names>S</given-names></name><name name-style="western"><surname>Weissman</surname><given-names>A. M</given-names></name><name name-style="western"><surname>Bonifacino</surname><given-names>J. S</given-names></name></person-group>
                    <year>2010</year>
                    <article-title>Serine residues in the cytosolic tail of the T-cell antigen
                        receptor alpha-chain mediate ubiquitination and endoplasmic
                        reticulum-associated degradation of the unassembled protein.</article-title>
                    <source>J Biol Chem</source>
                    <volume>285</volume>
                    <fpage>23916</fpage>
                    <lpage>23924</lpage>
                </element-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>DUB</term>
          <def>
            <p>deubiquitylating enzyme</p>
          </def>
        </def-item>
        <def-item>
          <term>EBV</term>
          <def>
            <p>Epstein-Barr virus</p>
          </def>
        </def-item>
        <def-item>
          <term>ER</term>
          <def>
            <p>endoplasmic reticulum</p>
          </def>
        </def-item>
        <def-item>
          <term>ERAD</term>
          <def>
            <p>ER-associated degradation</p>
          </def>
        </def-item>
        <def-item>
          <term>TCR</term>
          <def>
            <p>T cell antigen receptor</p>
          </def>
        </def-item>
        <def-item>
          <term>UPR</term>
          <def>
            <p>unfolded protein response</p>
          </def>
        </def-item>
        <def-item>
          <term>UPS</term>
          <def>
            <p>ubiquitin-proteasome system</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    
  </back>
</article>